Net Cash Provided by (Used in) Financing Activities of RESMED INC from 30 Jun 2010 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary: RESMED INC quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 30 Jun 2010 to 30 Sep 2025.
RESMED INC Net Cash Provided by (Used in) Financing Activities for the quarter ending 30 Sep 2025 was $230,274,000, a 53% decline year-over-year.
RESMED INC annual Net Cash Provided by (Used in) Financing Activities for 2025 was $606,253,000, a 46% increase from 2024.
RESMED INC annual Net Cash Provided by (Used in) Financing Activities for 2024 was $1,119,287,000, a 365% decline from 2023.
RESMED INC annual Net Cash Provided by (Used in) Financing Activities for 2023 was $422,874,000.
Source SEC data: View on sec.gov

Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)

Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

Net Cash Provided by (Used in) Financing Activities, Annual (USD)

Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

RESMED INC Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$230,274,000	-$79,517,000	-53%	01 Jul 2025	30 Sep 2025	10-Q	31 Oct 2025	2026	Q1
Q3 2024	$150,757,000	+$375,000	+0.25%	01 Jul 2024	30 Sep 2024	10-Q	31 Oct 2025	2026	Q1
Q3 2023	$151,132,000	-$109,252,000	-261%	01 Jul 2023	30 Sep 2023	10-Q	25 Oct 2024	2025	Q1
Q3 2022	$41,880,000	-$134,850,000	-145%	01 Jul 2022	30 Sep 2022	10-Q	27 Oct 2023	2024	Q1
Q3 2021	$92,970,000	+$268,228,000		01 Jul 2021	30 Sep 2021	10-Q	28 Oct 2022	2023	Q1
Q3 2020	$175,258,000	-$75,184,000	-75%	01 Jul 2020	30 Sep 2020	10-Q	29 Oct 2021	2022	Q1
Q3 2019	$100,074,000	-$244,898,000	-169%	01 Jul 2019	30 Sep 2019	10-Q	30 Oct 2020	2021	Q1
Q3 2018	$144,824,000	+$250,907,000		01 Jul 2018	30 Sep 2018	10-Q	25 Oct 2019	2020	Q1
Q3 2017	$106,083,000			01 Jul 2017	30 Sep 2017	10-Q	26 Oct 2018	2019	Q1
Q3 2012	$7,690,000	+$91,633,000		01 Jul 2012	30 Sep 2012	10-Q	31 Oct 2012	2013	Q1
Q3 2011	$83,943,000	-$47,459,000	-130%	01 Jul 2011	30 Sep 2011	10-Q	31 Oct 2012	2013	Q1
Q3 2010	$36,484,000			01 Jul 2010	30 Sep 2010	10-Q	03 Nov 2011	2012	Q1

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2025	$606,253,000	+$513,034,000	+46%	01 Jul 2024	30 Jun 2025	10-K	08 Aug 2025	2025	FY
2024	$1,119,287,000	-$1,542,161,000	-365%	01 Jul 2023	30 Jun 2024	10-K	08 Aug 2025	2025	FY
2023	$422,874,000	+$551,237,000		01 Jul 2022	30 Jun 2023	10-K	08 Aug 2025	2025	FY
2022	$128,363,000	+$636,269,000	+83%	01 Jul 2021	30 Jun 2022	10-K	09 Aug 2024	2024	FY
2021	$764,632,000	-$447,346,000	-141%	01 Jul 2020	30 Jun 2021	10-K	11 Aug 2023	2023	FY
2020	$317,286,000	-$897,929,000	-155%	01 Jul 2019	30 Jun 2020	10-K	12 Aug 2022	2022	FY
2019	$580,643,000	+$1,607,337,000		01 Jul 2018	30 Jun 2019	10-K	17 Aug 2021	2021	FY
2018	$1,026,694,000	-$763,827,000	-291%	01 Jul 2017	30 Jun 2018	10-K	13 Aug 2020	2020	FY
2017	$262,867,000	-$875,451,000	-143%	01 Jul 2016	30 Jun 2017	10-K	08 Aug 2019	2019	FY
2016	$612,584,000			01 Jul 2015	30 Jun 2016	10-K	17 Aug 2018	2018	FY
2013	$153,927,000	+$23,178,000	+13%	01 Jul 2012	30 Jun 2013	10-K	13 Aug 2013	2013	FY
2012	$177,105,000	-$97,762,000	-123%	01 Jul 2011	30 Jun 2012	10-K	13 Aug 2013	2013	FY
2011	$79,343,000	-$18,214,000	-30%	01 Jul 2010	30 Jun 2011	10-K	13 Aug 2013	2013	FY
2010	$61,129,000			01 Jul 2009	30 Jun 2010	10-K	14 Aug 2012	2012	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.